Home » Telix Completes TLX250-CDx (Zircaix®) BLA Submission for Kidney Cancer Imaging

Telix Completes TLX250-CDx (Zircaix®) BLA Submission for Kidney Cancer Imaging

by BioMelbourne Network | Jun 27, 2024 | Articles | 0 Comments